You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in the Philippines

Jun 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

Consumer health records stable growth in 2011

In 2011, consumer health in the Philippines saw similar retail value sales growth to that seen in both 2009 and 2010. Despite the increasing practice of preventive medicine, which resulted in strong retail value sales growth for vitamins and dietary supplements, slow demand in several categories, including medicated skin care, ear care, eye care, wound care and NRT smoking cessation aids, due to a lack of advertising support, greater competition from other industries and premature entry, hampered the overall performance of consumer health in the Philippines in 2011.

More Filipinos opt to invest in preventive health care

  • Despite the presence of a social health insurance programme, PhilHealth, the country’s public healthcare subsidies remained insufficient to cover all medical expenses. Although some financial support was available, hospitalisation costs remained unaffordable to the majority of the population. As a result, a greater number of Filipinos invested in preventive health care, regularly consuming products that help in strengthening immunity and in maintaining overall health and wellness, due to the belief that doing so is less expensive than contracting an ailment and being hospitalised.

Domestic player United Laboratories maintains leadership in 2011

  • United Laboratories maintained its leadership of consumer health in the Philippines in 2011, in accounting for a retail value sales share of 32% in 2011. The success of this domestic company was attributable to its well-diversified product portfolio, use of a low-pricing strategy, well-established distribution across various retail channels, aggressive advertising support for its main labels and the strong performance of a number of its brands, including Biogesic, Alaxan, Solmux and Ceelin, which have proven their effectiveness for decades in key consumer health categories.

Parapharmacies/drugstores remains the leading distribution channel

In 2011, Filipinos continued to prefer to purchase non-prescription medicines in parapharmacies/drugstores. This was mainly due to the extensive availability of branded and generic products through the channel, which enabled consumers to choose based on their budget, and better pricing. Chained retailers, such as Mercury Drug and South Star Drug, were also favoured because of the additional services provided, including loyalty cards, in-store promotions and the 24-hour operation of selected outlets, which offered convenience and cost savings to consumers.

Stronger growth is expected over the forecast period

Consumer health in the Philippines is expected to see stronger constant value sales growth over the forecast period compared to that recorded over the review period. The health and wellness, and preventive health care trends are anticipated to drive demand. A growing number of Filipinos are expected to increase their consumption of vitamins and dietary supplements, in order to strengthen their immune systems and maintain overall health and wellness, enabling them to cope better with their busier and more stressful lifestyles.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Philippines with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Philippines, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Philippines for free:

The Consumer Health in Philippines market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Philippines?
  • What are the major brands in Philippines?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in the Philippines - Industry Overview

EXECUTIVE SUMMARY

Consumer health records stable growth in 2011

More Filipinos opt to invest in preventive health care

Domestic player United Laboratories maintains leadership in 2011

Parapharmacies/drugstores remains the leading distribution channel

Stronger growth is expected over the forecast period

KEY TRENDS AND DEVELOPMENTS

Increasing demand for plant-based treatments

Line extensions become increasingly popular

Growing competition between consumer health and beauty and personal care

Celebrity endorsement remains a popular marketing tool

More Filipinos opt to invest in preventive health care

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Consumer Health Company Shares 2007-2011
  • Table 6 Consumer Health Brand Shares 2008-2011
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

DEFINITIONS

SOURCES

  • Summary 1 Research Sources

Consumer Health in the Philippines - Company Profiles

International Pharmaceuticals Inc in Consumer Health (Philippines)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 3 International Pharmaceuticals Inc: Competitive Position 2011

Macropharma Corp in Consumer Health (Philippines)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 5 Macropharma Corp: Competitive Position 2011

Pascual Laboratories Inc in Consumer Health (Philippines)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 7 Pascual Laboratories Inc: Competitive Position 2011

Philusa Corp in Consumer Health (Philippines)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 10 Philusa Corp: Competitive Position 2011

United Laboratories Inc in Consumer Health (Philippines)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 12 United Laboratories Inc: Competitive Position 2011

Adult Mouth Care in the Philippines - Category Analysis

HEADLINES

TRENDS

  • Usage of over-the-counter adult mouth care products remained incident-based in 2011. More often than not, Filipinos self-medicate, purchasing these products when the need to treat minor mouth-related problems arises. However, innovations in cosmetic mouthwashes and toothpastes, as well as low awareness of the main function of medicated mouth care remedies, significantly affected the performance of the category over the review period.

SWITCHES

COMPETITIVE LANDSCAPE

  • Johnson & Johnson remained the leading player in 2011, in accounting for a retail value sales share of 49%. The company also recorded the largest gain in retail value sales share of less than half a percentage point in 2011. The company’s success was based on the proven effectiveness of its Bactidol brand in treating minor mouth ailments, as well as its high brand recognition, wide presence through various retail channels and constant recommendations from medical specialists.

PROSPECTS

  • Demand for adult mouth care is expected to remain incident-based over the forecast period, with usage of over-the-counter remedies limited to when the need arises. Constant value sales of adult mouth care are expected to see a negative CAGR of 1% over the forecast period. The lack of proper knowledge on the difference between over-the-counter mouth care solutions and cosmetic mouthwashes is expected to be the key factor behind the expected decline in demand. Consumers are likely to show a growing preference for cosmetic mouthwashes, which are heavily supported with marketing and advertising campaigns.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2006-2011
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 13 Adult Mouth Care Company Shares by Value 2007-2011
  • Table 14 Adult Mouth Care Brand Shares by Value 2008-2011
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in the Philippines - Category Analysis

HEADLINES

TRENDS

  • The increasing preference for more potent and faster acting analgesics continued in 2011, due to the increasing number of Filipinos living fast-paced lifestyles. Growing demand for these types of medications resulted in new product developments. In early 2011, Pfizer expanded its Advil line with the introduction of Advil Liqui-Gel. In mid-2011, Pharma-Rex launched Cortal SQR. Both brands have similar positioning, offering quick relief from various types of pain.

SWITCHES

COMPETITIVE LANDSCAPE

  • United Laboratories maintained leadership of analgesics, in accounting for a retail value sales share of 56% in 2011. The company’s success was attributable to its low-pricing strategy and well-diversified portfolio in analgesics, which included leading brands such as Biogesic, Alaxan and Medicol, which have proven their effectiveness for decades. Its ability to establish diverse positioning for its products, with Alaxan targeting those suffering from muscular pain, while Biogesic is marketed as a fever reducer, as well as continuous advertising and marketing support also contributed to the company’s good performance.

PROSPECTS

  • Due to approaching maturity, analgesics is expected to see stable performance over the forecast period. With high household penetration for most categories, increasing consumption is anticipated to sustain retail volume sales growth. Those with higher disposable incomes and consumers who frequently need pain killers are foreseen to purchase extra units to keep for future use. However, the buying pattern for most Filipinos is predicted to remain incidence-based.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2006-2011
  • Table 18 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 19 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011
  • Table 20 Analgesics Company Shares by Value 2007-2011
  • Table 21 Analgesics Brand Shares by Value 2008-2011
  • Table 22 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 23 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in the Philippines - Category Analysis

HEADLINES

TRENDS

  • In 2011, calming and sleeping benefited from the ongoing growth of the country’s business process outsourcing industry. Irregular hours and constant changes in shifts for those working in call centres prompted higher consumption of calming and sleeping products. Increasingly busy lifestyles, particularly amongst those living in urban areas, due to work, chores and extra-curricular activities, also assisted in stimulating demand, as more Filipinos looked to improve the quality of their sleep.

SWITCHES

COMPETITIVE LANDSCAPE

  • Organica Neutraceuticals remained the leading player in calming and sleeping in 2011, in accounting for a retail value sales share of 46%. The company also posted the largest retail value sales share gain of less than half a percentage point in 2011. The company’s success was attributable to its early entry into calming and sleeping in the Philippines with the Sleepasil brand and its proven effectiveness. It also benefited from the health and wellness trend, as a growing number of consumers showed a preference for herbal-based remedies, due to the belief that these natural products are free from unwanted side effects.

PROSPECTS

  • Calming and sleeping is a relatively nascent category in the Philippines, with significant potential for further development over the forecast period. At the end of the review period, the category remained niche, catering mostly to students and call centre employees. Attracting other consumer groups with irregular working hours, such as nurses and doctors in residency, widening the price range and brand options available, as well as emphasising the safeness of using these products, most of which are herbal-based, is likely to result in a further expansion of the consumer base and drive demand over the forecast period.

CATEGORY DATA

  • Table 24 Sales of Calming and Sleeping: Value 2006-2011
  • Table 25 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 26 Calming and Sleeping Company Shares by Value 2007-2011
  • Table 27 Calming and Sleeping Brand Shares by Value 2008-2011
  • Table 28 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 29 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in the Philippines - Category Analysis

HEADLINES

TRENDS

  • The health and wellness trend, coupled with information campaigns through television commercials and print ads, resulted in a further increase in demand for herbal/traditional remedies in 2011. Pascual Laboratories, a purveyor of plant-based medicines, continued to invest heavily in advertising and marketing activities for its Ascof brand, in an attempt to highlight the benefits of using natural treatments over chemical-based drugs. Testimonials from early adopters on the effectiveness of these alternatives also assisted in encouraging consumer trial and switching to these products.

SWITCHES

COMPETITIVE LANDSCAPE

  • United Laboratories maintained its lead in CCA remedies, in accounting for a retail value sales share of 31% in 2011. Its success was attributable to the strong performance of its Neozep, Solmux and Tuseran brands, which were either the leading or second most popular brands in their respective categories. Proven effectiveness, affordable pricing, continuous marketing support and widespread availability in various retail channels were also key factors that assisted the company in sustaining demand for its products.

PROSPECTS

  • Over the forecast period, the purchasing of CCA remedies is expected to remain incidence-based, as the majority of the population will continue to have limited disposable income. The growing practice of preventive medicine is anticipated to further reinforce this pattern, even among upper-income consumers, due to the belief that there is a lower probability of getting sick with a healthy and strong immune system.

CATEGORY DATA

  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 32 Sales of Decongestants by Category: Value 2006-2011
  • Table 33 Sales of Decongestants by Category: % Value Growth 2006-2011
  • Table 34 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 35 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 36 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2007-2011
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2008-2011
  • Table 38 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in the Philippines - Category Analysis

HEADLINES

TRENDS

  • Over the review period, the health and wellness trend saw an increasing number of Filipinos become knowledgeable of ways to promote digestive health. Consumption of high fibre foods, regular intake of fibre supplements and regularly drinking pro-biotic drinks became more evident in 2011. Adapting healthier lifestyles reduced the need for digestive remedies, as the incidence of diarrhoea and hyperacidity, amongst other maladies, declined. As a result, digestive remedies saw relatively slow retail value sales growth of only 2% in 2011.

SWITCHES

COMPETITIVE LANDSCAPE

  • Johnson & Johnson remained the leading player in digestive remedies in the Philippines in 2011, in accounting for a retail value sales share of 36%. Its strong position was attributable to the enduring popularity of Bonamine and Imodium, which remained the leading brands in motion sickness remedies and diarrhoeal remedies, respectively, due to their proven effectiveness. The company also benefited from its aggressive advertising in the 1990s, which established high brand recognition for its products.

PROSPECTS

  • Over the forecast period, Filipinos are expected to place greater emphasis on taking preventive measures to minimise or completely avoid minor digestive ailments. Due to the health and wellness trend, more consumers are expected to incorporate high fibre foods in their diet, eat healthier meals at the right time, avoid overeating and exercise more frequently, resulting in better digestive health and lower demand for digestive remedies. As a result, all categories, other than laxatives and motion sickness remedies, are expected to see a decline in retail volume sales, while digestive remedies as a whole is expected to see limited retail value sales growth of 1% over the forecast period.

CATEGORY DATA

  • Table 40 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 41 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 42 Digestive Remedies Company Shares by Value 2007-2011
  • Table 43 Digestive Remedies Brand Shares by Value 2008-2011
  • Table 44 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 45 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in the Philippines - Category Analysis

HEADLINES

TRENDS

  • Ear care continued to see poor performance in 2011, with retail volume and value sales only recording marginal growth. Low demand was attributable to the majority of Filipinos practicing proper ear hygiene, something which is thought at an early age both at home and in school. Hence, there was minimal need for over-the-counter ear care remedies, as regular cleaning of the ears lessens the probability of the build up of ear wax and contracting of minor ear infections.

SWITCHES

COMPETITIVE LANDSCAPE

  • There were only a handful of companies offering over-the-counter ear care products in the Philippines in 2011, as the category remained unattractive to most manufacturers, due to limited demand. In 2011, Norgine continued to enjoy a near monopoly of sales, with its Otosol brand accounting for a retail value sales share of 97%.

PROSPECTS

  • Constant value sales are projected to see a negative CAGR of 3% over the forecast period, compared to the negative CAGR of 4% seen over the review period. Ear care is expected to remain a niche category with limited demand for over-the-counter remedies, as Filipinos are foreseen to continue their hygienic practice of regularly cleaning their ears, which will serve to minimise the incidence of ear infections and wax accumulation.

CATEGORY DATA

  • Table 46 Sales of Ear Care: Value 2006-2011
  • Table 47 Sales of Ear Care: % Value Growth 2006-2011
  • Table 48 Ear Care Company Shares by Value 2007-2011
  • Table 49 Ear Care Brand Shares by Value 2008-2011
  • Table 50 Forecast Sales of Ear Care: Value 2011-2016
  • Table 51 Forecast Sales of Ear Care: % Value Growth 2011-2016

Eye Care in the Philippines - Category Analysis

HEADLINES

TRENDS

  • Eye care only saw marginal retail value sales growth of less than 1% in 2011. Although Filipinos worked longer hours in front of the computer and air pollution in the country worsened, less demand was seen for eye care products, due to a lack of advertising and marketing activities from key players, such as Johnson & Johnson and GlaxoSmithKline.

SWITCHES

COMPETITIVE LANDSCAPE

  • Johnson & Johnson maintained its leading position in eye care in 2011, in accounting for a retail value sales share of 46%. The company also saw the largest gain in retail value sales share of less than half a percentage point in 2011. The company’s success was attributable to its early entry into eye care in the Philippines, Visine’s highly effective tagline, Gets the red out in 60 seconds, which remained in the minds of consumers, despite the lack of advertising campaigns in the recent years, affordable pricing and extensive distribution through various retail channels.

PROSPECTS

  • With the high cost of professional consultation, Filipinos are expected to continue to practice self-medication, especially in relation to eye care, where the available over-the-counter brands have proven their effectiveness in treating minor eye problems. Usage of these products is likely to remain irregular, as consumers grow more cautious of not straining or irritating their eyes with their daily activities.

CATEGORY DATA

  • Table 52 Sales of Eye Care by Category: Value 2006-2011
  • Table 53 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 54 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 55 Standard Eye Care by Positioning: % Value Breakdown 2007-2011
  • Table 56 Eye Care Company Shares by Value 2007-2011
  • Table 57 Eye Care Brand Shares by Value 2008-2011
  • Table 58 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 59 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in the Philippines - Category Analysis

HEADLINES

TRENDS

  • Herbal/traditional products posted retail value sales growth of 7% in 2011, compared to the figure of 6% seen in 2010. This robust performance was attributable to increasing consumer preference for safe treatments and the growing health and wellness trend in the Philippines. In 2011, companies continued to emphasise the safety of herbal/traditional products, which they claimed provide the same benefits as standard medicines without the risk of unwanted side effects

COMPETITIVE LANDSCAPE

  • Universal Robina maintained its leadership in herbal/traditional products in 2011, in accounting for a retail value sales share of 51%. Its success was solely attributable to the good performance of Maxx, which remained the company’s only brand in consumer health. The medicated confectionery brand benefited from its affordable pricing of Ps31.50 per 200g pack and widespread availability through both modern and traditional retailers. Street vendors continued to play a significant role in the distribution of Maxx. These sellers loiter around major roads throughout the day, thereby providing greater accessibility to consumers.

PROSPECTS

  • Greater preference amongst Filipinos for safer and effective remedies to minor ailments is expected to drive demand for herbal/traditional products over the forecast period. Companies, particularly local players, are expected to invest in research and development, in order to introduce more natural alternatives in key categories, such as analgesics, cough, cold and allergy remedies and medicated skin care, given the lack of herbal/traditional options available in these at the end of the review period.

CATEGORY DATA

  • Table 60 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 61 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 62 Herbal/Traditional Products Company Shares 2007-2011
  • Table 63 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 64 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 65 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in the Philippines - Category Analysis

HEADLINES

TRENDS

  • Competition between medicated skin care and cosmetic products became more intense in 2011. This was driven by the aggressive advertising and marketing campaigns of beauty and personal care companies, which continued to highlight the similar abilities of their products and medicated skincare products. This resulted in a blurring of the distinction between medicated and regular shampoos with anti-dandruff and anti-hair loss features, as well as vaginal antifungals and feminine washes, and strengthened the consumer perception that cosmetic brands are alternative options for the prevention and treatment of minor skin-related problems.

SWITCHES

COMPETITIVE LANDSCAPE

  • Johnson & Johnson remained the leading player in medicated skin care in the Philippines in 2011, in accounting for a retail value sales share of 43%. The company was able to sustain its position, due to the strong following for Nizoral and Troyd, its two leading medicated skin care brands, which have proven their effectiveness in treating fungal infections. Nevertheless, its retail value sales share remained stagnant from 2009, due to increasing competition from beauty and personal care products, particularly regular shampoos claiming to have anti-dandruff properties.

PROSPECTS

  • Usage of medicated skin care products is expected to remain incident-based over the forecast period. Most Filipinos purchase these over-the-counter remedies only when the need arises and discontinue use once the condition has cleared up. As a result of innovations in beauty and personal care products, including features that prevent common skin care problems, medicated skin care will face greater competition over the forecast period. A significant number of consumers are likely to show a preference for cosmetic brands, mainly due to better awareness, lower pricing and wider availability. As a result, retail value sales of medicated skin care are expected to see a negative CAGR of 1% over the forecast period.

CATEGORY DATA

  • Table 66 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 67 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 68 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 69 Medicated Skin Care Brand Shares by Value 2008-2011
  • Table 70 Hair Loss Treatments Brand Shares by Value 2008-2011
  • Table 71 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 72 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in the Philippines - Category Analysis

HEADLINES

TRENDS

  • Following implementation of the smoking ban by various local governments in their respective localities in 2010, a smoking ban was also declared in Metro Manila in the first half of 2011. The announcement was followed by a month-long information campaign to remind Filipinos of the Tobacco Regulation Act of 2003, which prohibits smoking in public areas. While the Metro Manila Development Authority ensured strict enforcement and monitoring of the smoking ban, there was not a significant impact on demand for NRT smoking cessation aids, which remained low, or in reducing the country’s smoking population, which increased further in 2011.

SWITCHES

COMPETITIVE LANDSCAPE

  • The number of players offering NRT smoking cessation aids in the country remained limited in 2011. Novartis Healthcare, which remained the sole manufacturer of over-the-counter NRT smoking cessation aids, offered only one brand in a single format. Its main competitor was Pfizer’s Champix, a prescription brand that was significantly more affordable and offered the flexibility of buying in tingi (per unit) format.

PROSPECTS

  • NRT smoking cessation aids is expected to remain a niche category over the forecast period. Despite increasing awareness of the harmful effects of smoking amongst Filipinos, usage of these products is anticipated to remain low, due to high pricing. Smokers with limited disposable income are likely to utilise more affordable methods to stop smoking.

CATEGORY INDICATORS

  • Table 73 Number of Smokers by Gender 2006-2011

CATEGORY DATA

  • Table 74 Sales of NRT Smoking Cessation Aids by Category: Value 2008-2011
  • Table 75 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2008-2011
  • Table 76 NRT Smoking Cessation Aids Company Shares by Value 2007-2011
  • Table 77 NRT Smoking Cessation Aids Brand Shares by Value 2008-2011
  • Table 78 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
  • Table 79 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016

Sports Nutrition in the Philippines - Category Analysis

HEADLINES

TRENDS

  • Sports nutrition continued as a niche category in 2011. Nevertheless, the health and wellness trend, greater exposure to models and celebrities with well-toned physiques through the media and growing consumer knowledge and awareness of the availability, benefits and uses of these products brought about an improvement in demand amongst men. This was particularly true in relation to male university students and young urban professionals from upper-middle and upper income segments.

COMPETITIVE LANDSCAPE

  • Total Nutrition remained the leading player in sports nutrition in the Philippines in 2011, in accounting for a retail value sales share of 38%. It also recorded the largest increase in retail value sales share of one percentage point in 2011. The company’s success was attributable to the good performance of GNC Pro Performance, the extensive network of GNC outlets in the Philippines, as well as its efforts to build awareness of sports nutrition products through information drives, event sponsorship and tie-ups with professional sports organisations and university athletic associations.

PROSPECTS

  • Sports nutrition is a relatively nascent category, with significant room for further development and expansion of the consumer base. Although it remained a niche category at the end of the review period, growing awareness of the benefits of using these products is expected to result in increased demand over the forecast period. This will be driven by the advertising efforts of key players and sports and fitness associations, as well as the health and wellness trend.

CATEGORY DATA

  • Table 80 Sales of Sports Nutrition: Value 2006-2011
  • Table 81 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 82 Sports Nutrition Company Shares 2007-2011
  • Table 83 Sports Nutrition Brand Shares 2008-2011
  • Table 84 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 85 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in the Philippines - Category Analysis

HEADLINES

TRENDS

  • A growing number of Filipinos put greater importance on preventive medicine in 2011, due to the lack of an efficient public healthcare system that provides hospitalisation subsidies, as well as the influence of the growing health and wellness trend. Vitamins and dietary supplements also benefited from increased consumption of these products amongst middle-income consumers, which drove performance in 2011.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • United Laboratories maintained its lead in vitamins and dietary supplements in 2011, in accounting for a retail value sales share of 31%. The company’s success was mainly based on its strong performance in vitamins, wherein it offered a well-diversified portfolio of adult and paediatric variants, including such top-of-mind as Ceelin, United American Tiki-Tiki, Enervon-C, Revicon Forte and Myra E, amongst others. These brands have proven their effectiveness for decades. Affordable pricing also enabled it to sustain demand and continuously increase its retail value sales share between 2007 and the end of the review period, despite increasing competition in the category.

PROSPECTS

  • Pharmaceutical and nutraceutical companies are expected to continue to invest heavily in research and development over the forecast period, in order to take advantage of rising demand for health and wellness products. New formulations and combinations are likely to be introduced over the forecast period, in response to changing consumer needs. The introduction of more herbal/traditional products is also anticipated, as Filipinos are likely to show a preference for safer alternatives, which have lower risks of harmful side effects.

CATEGORY DATA

  • Summary 13 Dietary Supplements: Brand Ranking by Positioning 2011
  • Table 86 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 87 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 88 Dietary Supplements by Positioning 2006-2011
  • Table 89 Vitamins and Dietary Supplements Company Shares by Value 2007-2011
  • Table 90 Vitamins and Dietary Supplements Brand Shares by Value 2008-2011
  • Table 91 Vitamins Brand Shares by Value 2008-2011
  • Table 92 Dietary Supplements Brand Shares by Value 2008-2011
  • Table 93 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 94 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016

Weight Management in the Philippines - Category Analysis

HEADLINES

TRENDS

  • Obesity became an increasing health problem in the Philippines over the review period. In 2011, 7% of the population aged 15 years and older were considered obese. With numerous life-threatening ailments connected to obesity, such as heart-related diseases and diabetes, amongst others, a growing number of Filipinos became concerned with their weight problems and opted to utilise weight management products.

COMPETITIVE LANDSCAPE

  • Roche remained the leading player in weight management in the Philippines in 2011, in accounting for a retail value sales share of 10%. Its success was attributable to its early entry into weight management in the Philippines, the proven effectiveness of its Xenical brand, which nearly monopolised sales in OTC obesity, and the continuous marketing and advertising support which the company provided for its products. Nevertheless, the company also recorded the largest decline in retail value sales share of one percentage point in 2011. Strong competition from more affordable categories, particularly slimming teas and weight loss supplements, negatively impacted the performance of Xenical in 2011.

PROSPECTS

  • The country’s increasing obesity rate and the growing incidence of heart-related problems, resulting from sedentary lifestyles and poor eating habits, is expected to sustain demand for weight management products over the forecast period. In addition to health concerns, the media’s influence on the perception of beauty in the country, which is equated to having a slim and well-toned physique, is also anticipated to contribute positively to demand over the forecast period.

CATEGORY DATA

  • Table 95 Sales of Weight Management: Value 2006-2011
  • Table 96 Sales of Weight Management: % Value Growth 2006-2011
  • Table 97 Weight Management Company Shares 2007-2011
  • Table 98 Weight Management Brand Shares 2008-2011
  • Table 99 Forecast Sales of Weight Management: Value 2011-2016
  • Table 100 Forecast Sales of Weight Management: % Value Growth 2011-2016

Wound Care in the Philippines - Category Analysis

HEADLINES

TRENDS

  • There were no visible new developments seen in delivery formats, materials or packaging in wound care in 2011, nor did any new players enter. As usage is incident-based, key companies opted not to invest in advertising and marketing activities and instead focused on expanding their distribution, in order to improve availability across the country and serve more consumers in need of these products.

COMPETITIVE LANDSCAPE

  • Philusa remained the leading player in 2011, accounting for a retail value sales share of 62%. The local company also continued to strengthen its position in wound care, in seeing the largest gain in retail value sales share of less than half a percentage point in 2011. The company’s success was attributable to the strong performance of Mediplast in both sticking plasters/adhesive bandages, and gauze, tape and other wound care products, wherein it remained the leading brand. This was driven by the brand’s affordable pricing, high brand recognition and extensive distribution through various retail channels.

PROSPECTS

  • The usage of wound care products in the Philippines is expected to remain incident-based over the forecast period. Retail value sales are expected to see a negative CAGR of 1% over the forecast period. The perception that wounds heal faster if they are left exposed after cleaning with antiseptic products and consumers becoming more cautious to avoid minor cuts and accidents are some of the factors that are expected to contribute to a contraction of retail volume and value sales over the forecast period.

CATEGORY DATA

  • Table 101 Sales of Wound Care by Category: Value 2006-2011
  • Table 102 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 103 Wound Care Company Shares by Value 2007-2011
  • Table 104 Wound Care Brand Shares by Value 2008-2011
  • Table 105 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 106 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Milk Thistle
            • Saw Palmetto
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Glutathione
            • Other Other Non-Herbal Dietary Supplements
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Paediatric Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Paediatric Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Paediatric Consumer Health
      • Paediatric Analgesics
        • Paediatric Acetaminophen
        • Paediatric Aspirin
        • Paediatric Combination Products - Analgesics
        • Paediatric Diclofenac
        • Paediatric Dipyrone
        • Paediatric Ibuprofen
        • Paediatric Ketoprofen
        • Paediatric Naproxen
      • Paediatric Cough, Cold and Allergy Remedies
        • Paediatric Allergy Remedies
        • Paediatric Cough/Cold Remedies
      • Paediatric Digestive Remedies
        • Paediatric Diarrhoeal Remedies
        • Paediatric Indigestion and Heartburn Remedies
        • Paediatric Laxatives
        • Paediatric Motion Sickness Remedies
      • Paediatric Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Paediatric Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!